1-5 of 5
Michael Schwarzinger
Close
Sort by
Journal Articles

First-Line Rituximab Efficacy and Safety in Patients with Acquired Idiopathic Thrombotic Thrombocytopenic Purpura Experiencing a Non Optimal Response to Therapeutical Plasma Exchange: Results of a Prospective Multicenter Phase 2 Study From the French Reference Center for the Management of Thrombotic Microangiopathies.

Antoine Froissart, Marc Buffet, Agnes Veyradier, Pascale Poullin, François Provot, Sandrine Malot, Michael Schwarzinger, Lionel Galicier, Philippe Vanhille, Jean-Paul Vernant, Dominique Bordessoule, Bertrand Guidet, Elie Azoulay, Eric Rondeau, Jean-Paul Mira, Alain Wynckel, Karine Clabault, Gabriel Choukroun, Claire Presne, Jacques Pourrat, Mohamed Hamidou, Linda Gimeno, Paul Coppo
Journal: Blood
Blood (2009) 114 (22): 890.
https://doi.org/10.1182/blood.V114.22.890.890
Published: 2009
Journal Articles

Cost-Effectiveness of Antifungal Strategies in High-Risk Neutropenic Patients

Michael Schwarzinger, Sylvain Baillot, Celine Beauchamp, Sebastien Maury, C. écile Pautas, MD, Anne Vekhoff, Hassan Farhat, Felipe Suarez, Francois Hemery, Mathieu Kuentz, MD, Catherine Cordonnier, MD
Journal: Blood
Blood (2008) 112 (11): 1314.
https://doi.org/10.1182/blood.V112.11.1314.1314
Published: 2008
Journal Articles

Cost-Effectiveness of Antifungal Strategies in High-Risk Neutropenic Patients.

Michael Schwarzinger, MD, PhD, Sylvain Baillot, MSc, Céline Beauchamp, MSc, Sébastien Maury, MD, PhD, Cécile Pautas, MD, Anne Vekhoff, MD, Hassan Farhat, MD, Felipe Suarez, MD, Mathieu Kuentz, MD, Catherine Cordonnier, MD
Journal: Blood
Blood (2007) 110 (11): 4340.
https://doi.org/10.1182/blood.V110.11.4340.4340
Published: 2007
Journal Articles

Empirical Versus Pre-Emptive Antifungal Therapy in High-Risk Febrile Neutropenic Patients: A Prospective Randomized Study.

Catherine Cordonnier, MD, Cecile Pautas, MD, Sebastien Maury, MD, PhD, Anne Vekhoff, MD, Hassan Farhat, MD, Felipe Suarez, MD, Maria Basile, MD, Francoise Isnard, MD, Lionel Ades, MD, Frederique Kuhnoski, MD, Oumady Reman, MD, Sami Chehata, MD, Thierry De Revel, MD, Stephane Lepretre, MD, Emmanuel Raffoux, MD, Stephane Bretagne, MD, PhD, Michael Schwarzinger, MD
Journal: Blood
Blood (2006) 108 (11): 2019.
https://doi.org/10.1182/blood.V108.11.2019.2019
Published: 2006
Journal Articles

Empirical Versus Pre-Emptive Antifungal Therapy in High-Risk Febrile Neutropenic Patients: An Economic Analysis.

Michael Schwarzinger, MD, PhD, Celine Beauchamp, PhD, Sebastien Maury, MD PhD, Cecile Pautas, MD, Anne Vekhoff, MD, Hassan Farhat, MD, Felipe Suarez, MD, François Hemery, MD, Mathieu Kuentz, MD, Patrick Maison, MD PhD, Catherine Cordonnier, MD
Journal: Blood
Blood (2006) 108 (11): 2021.
https://doi.org/10.1182/blood.V108.11.2021.2021
Published: 2006